A detailed history of Gleason Group, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Gleason Group, Inc. holds 84 shares of BAX stock, worth $3,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Previous 302 72.19%
Holding current value
$3,042
Previous $12,000 83.33%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$32.87 - $43.55 $7,165 - $9,493
-218 Reduced 72.19%
84 $2,000
Q1 2024

Apr 12, 2024

BUY
$37.88 - $43.77 $75 - $87
2 Added 0.67%
302 $12,000
Q4 2023

Jan 19, 2024

BUY
$31.71 - $38.95 $63 - $77
2 Added 0.67%
300 $11,000
Q3 2023

Oct 12, 2023

BUY
$37.32 - $49.29 $74 - $98
2 Added 0.68%
298 $11,000
Q2 2023

Jul 20, 2023

BUY
$39.98 - $47.68 $79 - $95
2 Added 0.68%
296 $13,000
Q1 2023

Apr 14, 2023

BUY
$37.58 - $52.57 $75 - $105
2 Added 0.68%
294 $11,000
Q4 2022

Jan 11, 2023

BUY
$49.7 - $57.71 $99 - $115
2 Added 0.69%
292 $0
Q3 2022

Oct 11, 2022

BUY
$53.86 - $66.8 $53 - $66
1 Added 0.35%
290 $16,000
Q2 2022

Jul 13, 2022

BUY
$63.83 - $80.0 $63 - $80
1 Added 0.35%
289 $19,000
Q1 2022

Apr 22, 2022

BUY
$76.85 - $89.45 $76 - $89
1 Added 0.35%
288 $22,000
Q4 2021

Jan 18, 2022

BUY
$74.57 - $87.19 $74 - $87
1 Added 0.35%
287 $25,000
Q3 2021

Oct 12, 2021

BUY
$73.77 - $83.61 $73 - $83
1 Added 0.35%
286 $23,000
Q2 2021

Jul 27, 2021

BUY
$80.5 - $88.01 $80 - $88
1 Added 0.35%
285 $23,000
Q1 2021

Apr 14, 2021

BUY
$76.38 - $86.03 $76 - $86
1 Added 0.35%
284 $24,000
Q4 2020

Jan 28, 2021

BUY
$75.39 - $82.36 $75 - $82
1 Added 0.35%
283 $23,000
Q2 2020

Aug 27, 2020

BUY
$78.66 - $94.14 $78 - $94
1 Added 0.36%
282 $24,000
Q4 2019

Aug 27, 2020

BUY
$76.7 - $88.45 $21,552 - $24,854
281 New
281 $23,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.3B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Gleason Group, Inc. Portfolio

Follow Gleason Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.